Penn Medicine researchers found psilocybin impacts brain circuits, offering new paths for pain and mental health. It reduces pain & depression in mice by targeting the ACC, showing potential as a non-addictive therapy.
Two mushroom teams uniquely create psilocybin, yielding similar results. This discovery boosts biotech psilocybin antidepressant manufacturing but leaves nature's purpose uncertain. Psilocybin aids cancer patients' mental health.
New ReSPCT guidelines address inconsistent psychedelic trial results by standardizing psychosocial context. International expert consensus aims to improve reliability and therapeutic potential of psychedelic treatments.
